Astrantus’s Cintas CTAS Stock Holding History

Astrantus’s Portfolio CTAS Stock Details CTAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-4,800	Closed	-$532K	–	201
2021 Q4	$532K	Buy	+4,800	New	+$517K	0.4%	108

Other funds holding CTAS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Astrantus's CTAS Position: Q1 2022 in Review

Astrantus sold out of Cintas (CTAS) in Q1 2022, closing a stake of 4,800 shares — an estimated $532K sold.

Astrantus first reported a position in CTAS in Q4 2021 and held it in 1 quarter. The position peaked at $532K in Q4 2021. 923 funds tracked by Wall St. Rank hold CTAS as of Q1 2022.

Astrantus reported no remaining Cintas position as of Q1 2022 after selling out during the quarter.
Astrantus sold 4,800 Cintas shares in Q1 2022, an estimated $532K.
Astrantus first reported a position in Cintas in Q4 2021 and held it in 1 quarter.
Astrantus's Cintas position peaked at $532K in Q4 2021.
923 funds tracked by Wall St. Rank held Cintas as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.